South Korea's top 100 firms exhibited a combined market value of 1,745 trillion won on Thursday, up 77.5 percent from 983 trillion won five years ago amid a recent stock market rally.
According to the data from market researcher CXO Institute, the latest tally was a 43.1 percent increase from last year.
Samsung Electronics Co. remains the top-cap South Korean company with 495.5 trillion won, followed by SK hynix Inc. with 91.7 trillion won, and LG Chem Ltd. with 62.8 trillion won.
The highest on-year growth rate among the 100 firms was shown by Shinpoong Pharmaceutical Co., whose market value shoot up 1,567 percent on-year to 6.5 trillion won this year.
New entrants to the top 100 list include SK Biopharmaceuticals Co., Big Hit Entertainment, and Kakao Games Corp. The three firms made a blockbuster debut on the local bourse last year.
The South Korean stock market has been on a roll in recent months due to a growing optimism over an economic recovery.


US Stock Futures Slip Ahead of Fed Decision, Big Tech Earnings Amid Middle East Tensions
BOJ Expected to Hold Rates Steady While Signaling More Hikes Ahead
Gold Prices Rise as Weak Dollar, Fed Rate Decision in Focus
Australia Inflation Cools as Core CPI Misses Forecasts, Easing RBA Rate Hike Pressure
Nvidia Invests $1 Billion in Naver as South Korea AI Data Center Expansion Gains Momentum
Oil Prices Jump 4% as Iran Missile Strike Revives Middle East Supply Fears
Nvidia Eyes $250B Guarantee for OpenAI’s Massive Ohio AI Data Center Project
Asian Stocks Sink as AI Spending Fears and China Chip Advances Hit Tech Shares
Hong Kong Home Prices Extend Winning Streak With 13th Straight Monthly Gain in June
X Challenges Australia’s Expanded Social Media Ban Enforcement Powers
RBA Signals More Rate Hikes Possible as Australia Battles Stubborn Inflation
Serica Energy to Acquire Pharos Energy for £145.7M, Sending PHARP Shares Soaring
TSMC Gradually Restarts Japan Chip Plant After Kumamoto Earthquake
Johnson & Johnson Proposes $5.5 Billion Talc Settlement to Resolve U.S. Ovarian Cancer Lawsuits
Dollar Holds One-Month High as Fed Rate Hike Bets Grow, Yen Remains Under Pressure
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
US Stock Futures Slip Ahead of Big Tech Earnings, Fed Decision as Nvidia Leads Chip Selloff 



